Learner Objectives

After participating in this activity, learners should be able to:

Episode Specific:
  • Summarize the history and background of opioid prescribing legislation over the years.
  • List the stakeholders involved in addressing the opioid use public health crisis in Washington state.
  • Understand the effects of HB1427 and SB5380 on opioid prescribing in Washington state and have strategies to comply with them.
  • Get engaged in Olympia and testify on rules and regulation of important medical issues.
Podcast Series:
  • Increase safe opioid prescribing practices in line with HB1427.
  • Have strategies to tailor opioid management services to their specialty and organization using evidence-based practices on appropriate prescribing and data-driven practices.
  • Help reduce the development of tolerance to opioids.
  • Address long-term pain management, and appropriately treat opioid addiction.
1=Poor23=Good45=Excellent
1=Poor23=Good45=Excellent
Content Expertise
Communication Skills
1=Poor23=Good45=Excellent
Content Expertise
Communication Skills

An “ineligible company,” also known as a "commercial interest," is defined as any entity producing, marketing, selling, re-selling or distributing health care goods or services consumed by, or used on, patients. Among the exemptions to this definition are government organizations, non-health care related companies and non-profit organizations that do not advocate for commercial interests.

Did you perceive any bias toward a “commercial interest” in any presentation?
Do you want CME credit?(Required)